The fact
The stock experiences volume variations despite promising fundamentals in cancer treatment.
Transatlantic expansion is a major catalyst for French biotech valuation.
Click the link to read an article on the topic:
The stock experiences volume variations despite promising fundamentals in cancer treatment.
Transatlantic expansion is a major catalyst for French biotech valuation.